Benzodiazepine anticonvulsants

WATSON 240 0.5 Pill - white round, 6mm

Pill with imprint WATSON 240 0.5 is White, Round and has been identified as Lorazepam 0.5 mg. It is supplied by Watson Laboratories, Inc.

Lorazepam is used in the treatment of Anxiety; ICU Agitation; Insomnia; Light Anesthesia; Nausea/Vomiting and belongs to the drug classes benzodiazepine anticonvulsants, benzodiazepines, miscellaneous antiemetics. There is positive evidence of human fetal risk during pregnancy. Lorazepam 0.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images

Lorazepam (injection) (Lorazepam (injection) [ lor-a-ze-pam ])-WATSON 240 0.5-0.5 mg-White-Round
Lorazepam (injection) (Lorazepam (injection) [ lor-a-ze-pam ])-WATSON 240 0.5-0.5 mg-White-Round
Lorazepam (injection) (Lorazepam (injection) [ lor-a-ze-pam ])-WATSON 240 0.5-0.5 mg-White-Round
Lorazepam (injection) (Lorazepam (injection) [ lor-a-ze-pam ])-WATSON 240 0.5-0.5 mg-White-Round
Lorazepam (injection) (Lorazepam (injection) [ lor-a-ze-pam ])-WATSON 240 0.5-0.5 mg-White-Round

Lorazepam (injection)
Generic Name: lorazepam (injection) [ lor-a-ze-pam ]
Imprint: WATSON 240 0.5
Strength: 0.5 mg
Color: White
Size: 6.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Benzodiazepine anticonvulsants Benzodiazepines Miscellaneous antiemetics
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: 4 - Some potential for abuse
Labeler / Supplier: N/A
National Drug Code (NDC): N/A
Inactive Ingredients: Lactose, Magnesium stearate, Microcrystalline cellulose, Polacrilin potassium,
Latest News
Related Drugs